3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
20
Phase 1
19
Phase 1/2
13
Phase 3
8
Phase NA
3
Phase EARLY_PHASE1
2
Phase 2/3
2
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
2
Dermatologic
2
Thoracic
1
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
88
Lung Neoplasms
70
Small Cell Lung Carcinoma
11
Pleural Effusion, Malignant
9
Melanoma
7
Ovarian Neoplasms
6
NSCLC
6
Pleural Effusion
5
Neoplasms
5
Head and Neck Neoplasms
5
Stomach Neoplasms
4
Mesothelioma
4
Lung Diseases
4
Carcinoma, Renal Cell
4
Carcinoma
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Thoracic Neoplasms
3
Pneumothorax
3
Pleural Neoplasms
3
Pancreatic Neoplasms
3
Non-Squamous Non-Small Cell Lung Cancer
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Hepatocellular
3
Brain Neoplasms
3
Venous Thromboembolism
2
Urinary Bladder Neoplasms
2
Interventions
Carboplatin
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Carcinoma, Squamous Cell
×
Thoracic
×
Clear all
NCT02151149
2018-09-24
ABOUND 70+
Celgene
Phase 4
Completed
143 enrolled
25 charts